Susan G. Komen® Announces 2023 Grants to Accelerate Research Discoveries and Improve Outcomes for Breast Cancer Patients

Susan G. Komen® Announces 2023 Grants to Accelerate Research Discoveries and Improve Outcomes for Breast Cancer Patients Published: Jun 28, 2023 &nbsp $19.3 Million in Funding to Leading and Emerging Scientists; Grants will Advance Precision Medicine and Eliminate Disparities in Breast Cancer DALLAS, June 28, 2023 /PRNewswire/ -- Susan G. Komen for the Cure®, the world's leading breast cancer or..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 29.
  • textsms

DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico

DNAnexus Platform Enables Researchers to Access and Analyze Biomedical Data for Largest Health Research Program in Mexico &nbsp Mexico City Prospective Study is a strategic collaboration between Universidad Nacional Autónoma de México and Oxford Population Health &nbsp MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- DNAnexus, Inc. the leading provider of cloud-based genomic and biomedical data access a..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 28.
  • textsms

Department of Health - Abu Dhabi, M42 and AbbVie Enter Strategic Partnership for Personalized Medicine and Genomics

The Department of Health – Abu Dhabi (DoH) has signed a Memorandum of Understanding with AbbVie Biopharmaceutical and M42 to advance personalised medicine and genomics in Abu Dhabi. The three parties aim to advance precision medicine in the diagnosis and treatment of multiple myeloma and non-small cell lung cancer. This strategic cooperation aims to maximise on the Emirate's unique genomics prog..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 6. 20.
  • textsms